Quantcast

Latest angina Stories

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-09-14 12:20:52

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time WASHINGTON, Sept. 14, 2014 /PRNewswire/ -- Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic XIENCE family of DES. The trial,...

2013-03-12 23:01:16

Pain reduction effects of ranolazine most pronounced in patients with poor glucose control A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Ranolazine is approved by the U.S. Food and Drug Administration for the treatment of chronic angina, or chest pain, both...

2012-02-28 14:48:00

A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical therapy for prevention of death, nonfatal heart attacks, unplanned revascularization or angina, according to a study published in the Feb. 27 Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less is More series. While...

2011-12-21 22:55:11

Scots of Pakistani origin are 50 percent more likely to be admitted to hospital with chest pain and angina than those of Indian ethnicity, a study has found Scots of Pakistani origin are 50 per cent more likely to be admitted to hospital with chest pain and angina than those of Indian ethnicity, a study has found. Scots of Indian and Pakistani origin also have much greater levels of hospital admissions for both conditions than people of white Scottish ethnicity. Those of Pakistani...

2011-07-08 14:03:57

Study finds improvement in chest pain and exercise tolerance New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options). The phase II prospective, double-blind, randomized, controlled clinical trial was conducted at 26 centers in the...

2011-07-08 13:47:59

An injection of stem cells into the heart could offer hope to many of the 850,000 Americans whose chest pain doesn't subside even with medicine, angioplasty or surgery, according to a study in Circulation Research: Journal of the American Heart Association. Patients who received the new treatment reported half as many chest pain episodes and improved exercise capability compared to those who received a placebo. The study was the first randomized, controlled trial of stem-cell therapy to show...

2011-03-18 00:00:26

Indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease Cranford, NJ (PRWEB) March 16, 2011 Coronary artery disease (CAD), also known as coronary heart disease, is the most common type of heart disease, currently affecting about 17 million Americans.(1) Most of these people suffer from a common symptom of CAD known as angina pectoris. For over 100 years, physicians have treated acute angina with nitrates, the most common form being...

2011-03-16 02:00:00

CRANFORD, N.J., March 16, 2011 /PRNewswire/ -- Coronary artery disease (CAD), also known as coronary heart disease, is the most common type of heart disease, currently affecting about 17 million Americans(1). Most of these people suffer from a common symptom of CAD known as angina pectoris. For over 100 years, physicians have treated acute angina with nitrates, the most common form being nitroglycerin(2). Considered the gold standard in treating acute angina, nitroglycerin tablets have...

2010-12-23 17:08:30

Are negative aspects of social relations predictive of angina pectoris? A 6-year follow-up study of middle-aged Danish women and men Shouldering family demands and worries seems to increase the risk of angina, the precursor to coronary artery disease, reveals research published online in the Journal of Epidemiology and Community Health. Previous research has indicated that rewarding personal relationships are a boost for heart health, so the authors wanted to know if the reverse might also be...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related